Cancer treatments represented a third of medicines in clinical trials in 2023: report
Cancer treatments represented 33 per cent of medicines in all phases of clinical trials in 2023, followed by treatments for infectious diseases (13 per cent)…
- By: Staff
- November 15, 2024 November 14, 2024
- 09:00